Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2020 | 3 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Phosphatidylserine Synthase PTDSS1 Shapes the Tumor Lipidome to Maintain Tumor-Promoting Inflammation.
Cancer Res. 2022 Apr 15;82(8):1617-1632. doi: 10.1158/0008-5472.CAN-20-3870.
Cancer Res. 2022.
PMID: 35425959
Mouse CD38-Specific Heavy Chain Antibodies Inhibit CD38 GDPR-Cyclase Activity and Mediate Cytotoxicity Against Tumor Cells.
Baum N, Eggers M, Koenigsdorf J, Menzel S, Hambach J, Staehler T, Fliegert R, Kulow F, Adam G, Haag F, Bannas P, Koch-Nolte F.
Baum N, et al.
Front Immunol. 2021 Sep 3;12:703574. doi: 10.3389/fimmu.2021.703574. eCollection 2021.
Front Immunol. 2021.
PMID: 34539634
Free PMC article.
Item in Clipboard
Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD+ Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells.
Baum N, Fliegert R, Bauche A, Hambach J, Menzel S, Haag F, Bannas P, Koch-Nolte F.
Baum N, et al.
Cancers (Basel). 2020 Dec 30;13(1):76. doi: 10.3390/cancers13010076.
Cancers (Basel). 2020.
PMID: 33396591
Free PMC article.
Item in Clipboard
Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies.
Schriewer L, Schütze K, Petry K, Hambach J, Fumey W, Koenigsdorf J, Baum N, Menzel S, Rissiek B, Riecken K, Fehse B, Röckendorf JL, Schmid J, Albrecht B, Pinnschmidt H, Ayuk F, Kröger N, Binder M, Schuch G, Hansen T, Haag F, Adam G, Koch-Nolte F, Bannas P.
Schriewer L, et al. Among authors: baum n.
Theranostics. 2020 Feb 3;10(6):2645-2658. doi: 10.7150/thno.38533. eCollection 2020.
Theranostics. 2020.
PMID: 32194826
Free PMC article.
Item in Clipboard
Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs).
Hambach J, Riecken K, Cichutek S, Schütze K, Albrecht B, Petry K, Röckendorf JL, Baum N, Kröger N, Hansen T, Schuch G, Haag F, Adam G, Fehse B, Bannas P, Koch-Nolte F.
Hambach J, et al. Among authors: baum n.
Cells. 2020 Jan 29;9(2):321. doi: 10.3390/cells9020321.
Cells. 2020.
PMID: 32013131
Free PMC article.
Item in Clipboard
Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors.
Eichhoff AM, Börner K, Albrecht B, Schäfer W, Baum N, Haag F, Körbelin J, Trepel M, Braren I, Grimm D, Adriouch S, Koch-Nolte F.
Eichhoff AM, et al. Among authors: baum n.
Mol Ther Methods Clin Dev. 2019 Sep 16;15:211-220. doi: 10.1016/j.omtm.2019.09.003. eCollection 2019 Dec 13.
Mol Ther Methods Clin Dev. 2019.
PMID: 31687421
Free PMC article.
Item in Clipboard
Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies.
Tintelnot J, Baum N, Schultheiß C, Braig F, Trentmann M, Finter J, Fumey W, Bannas P, Fehse B, Riecken K, Schuetze K, Bokemeyer C, Rösner T, Valerius T, Peipp M, Koch-Nolte F, Binder M.
Tintelnot J, et al. Among authors: baum n.
Mol Cancer Ther. 2019 Apr;18(4):823-833. doi: 10.1158/1535-7163.MCT-18-0849. Epub 2019 Mar 1.
Mol Cancer Ther. 2019.
PMID: 30824613
Item in Clipboard
Cite
Cite